Identification and distribution of novel metabolites of lolitrem B in mice by high-resolution mass spectrometry

6Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Lolitrem B is the most potent indole-diterpene mycotoxin produced by Epichloë festucae var. lolii (termed LpTG-1), with severe intoxication cases reported in livestock. To date, there are no in vivo metabolism studies conducted for the mycotoxin. A mouse model assay established for assessing toxicity of indole-diterpenes was used to investigate metabolic products of lolitrem B. Mice were administered lolitrem B at 0.5 and 2.0 mg/kg body weight (b.wt) intraperitoneally before body and brain tissues were collected at 6 h and 24 h post-treatment. Samples were cryoground and subjected to a biphasic or monophasic extraction. The aqueous and lipophilic phases were analysed using liquid chromatography high-resolution mass spectrometry (LC–HRMS); data analysis was performed with Compound Discoverer™ software. A total of 10 novel phase I metabolic products were identified in the lipophilic phase and their distribution in the liver, kidney and various brain regions are described. The biotransformation products of lolitrem B were found to be present in low levels in the brain. Based on structure–activity postulations, six of these may contribute towards the protracted tremors exhibited by lolitrem B-exposed animals.

Cite

CITATION STYLE

APA

Reddy, P., Elkins, A., Hemsworth, J., Guthridge, K., Vassiliadis, S., Read, E., … Rochfort, S. (2020). Identification and distribution of novel metabolites of lolitrem B in mice by high-resolution mass spectrometry. Molecules, 25(2). https://doi.org/10.3390/molecules25020372

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free